XIENCE Sierra™ 1550225-33Recalls & reported problems
Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 2.25 mm x 33 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE Sierra (56)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648227059), received between Mar 8, 2020 and Apr 8, 2022 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Material Separation” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Separation1
- Migration1
Patient problems
- Angina1
- Cardiac Enzyme Elevation1
- Dyspnea1
- No Clinical Signs, Symptoms or Conditions1
- Pain1
- Stenosis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryApr 8, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
PATIENT ID: (B)(6). IT WAS REPORTED THAT ON (B)(6) 2019, THE PATIENT UNDERWENT A CORONARY STENTING PROCEDURE, WITH IMPLANT OF A 2.25 X 33 MM XIENCE SIERRA STENT IN THE MID LEFT ANTERIOR DESCENDING CORONARY ARTERY (MLAD). ON (B)(6) 2019, THE PATIENT WAS RE-HOSPITALIZED WITH CHEST PAIN AND SHORTNESS OF BREATH. CARDIAC ENZYMES WERE ELEVATED. CARDIAC CATHETERIZATION SHOWED 70% STENOSIS IN THE MLAD. A REVASCULARIZATION PROCEDURE WAS PERFORMED ON (B)(6) 2019, WITH IMPLANT OF AN ADDITIONAL STENT IN THE MLAD, RESOLVING THE EVENT. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Cardiac Enzyme Elevation; Dyspnea; Stenosis
MAUDE report 14060007 ↗MalfunctionFeb 22, 2021Material Separation; Migration; Material Separation; Migration
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MILDLY CALCIFIED, HEAVILY TORTUOUS LEFT ANTERIOR DESCENDING ARTERY (LAD). ON (B)(6) 2020, A 2.25X33MM XIENCE SIERRA WAS IMPLANTED AT THE LESION WITHOUT ISSUE. DURING THE FOLLOW UP VISIT ON (B)(6) 2021, THE PHYSICIAN NOTED THAT THE STENT IMPLANT WAS FRACTURED IN TWO SEPARATE PIECES AND HAD MIGRATED A BIT DISTALLY, STILL REMAINING ON THE LAD TARGET LESION. NO TREATMENT HAS BEEN PERFORMED. NO DISTAL FLOW INTERRUPTION WAS NOTED. THERE WAS NO ADVERSE PATIENT SEQUELA AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11362658 ↗InjuryMar 8, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2019 THE PATIENT PRESENTED WITH NON-ST ELEVATED MYOCARDIAL INFARCTION (NSTEMI). A 2.25X33MM XIENCE SIERRA STENT WAS IMPLANTED. ON (B)(6) 2019 THE PATIENT WAS RE-HOSPITALIZED WITH RIGHT SHOULDER PAIN. IT IS UNKNOWN WHAT TREATMENT WAS PERFORMED AND WHAT THE FINAL PATIENT OUTCOME WAS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Pain
MAUDE report 9803948 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page